 |

Musculoskeletal Syndromes Associated With Malignancy (Excluding Hypertrophic Osteoarthropathy) CME DisclosuresRelease Date: February 27, 2008; Valid for credit through February 27, 2009 | | Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians |  | 
| Contents of This CME Activity |  |
| Legal Disclaimer |  |
 | The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
 |

Learning Objectives Upon completion of this activity, participants will be able to: - Describe the classification of musculoskeletal disorders associated with malignancy
- List the Bradford Hill criteria to determine causation and outcome
- Identify rheumatic disorders caused by cancer
- Identify rheumatic conditions that can undergo malignant transformation
- Describe cancers that are most likely to be associated with different rheumatologic conditions
Authors and Disclosures
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
 |